ALNY Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ALNY Shares Outstanding History and ALNY YTD Return |
ALNY Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: ALNY Shares Outstanding History and ALNY YTD Return |
ALNY Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+27.51% CAGR Mouse over chart for data details
|
ALNY Stock Price Chart |
About Alnylam Pharmaceuticals Inc |
Alnylam Pharmaceuticals is a global biopharmaceutical company developing therapeutics based on ribonucleic acid interference (RNAi). Co. has four RNAi-based medicines, ONPATTRO® (patisiran), GIVLAARI® (givosiran), OXLUMO® (lumasiran) and Leqvio® (inclisiran). ONPATTRO is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. GIVLAARI is approved for the treatment of adults with acute hepatic porphyria. Co. has approval for OXLUMO for the treatment of primary hyperoxaluria type 1 in all age groups. Leqvio (inclisiran) is being developed and commercialized for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. We show 57 historical shares outstanding datapoints in our ALNY shares outstanding history coverage, used to compute ALNY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALNY market cap history over the course of time is important for investors interested in comparing ALNY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALNY versus a peer is one thing; comparing ALNY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALNY can fluctuate over the course of history. With this page we aim to empower investors researching ALNY by allowing them to research the ALNY market cap history. |
ALNY Current Stock Quote |
Free ALNY Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
ALNY Share Performance |
Market Cap Peers |
Alnylam Pharmaceuticals (ALNY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ALOG Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.